Aspiration & Biopsy Needles Market Analysis and Forecast to 2031: By Product Type (Biopsy Needles, Aspiration Needles), Application (Tumor/ Cancer Application, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marr

Aspiration & Biopsy Needles Market Analysis and Forecast to 2031: By Product Type (Biopsy Needles, Aspiration Needles), Application (Tumor/ Cancer Application, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, Other Cancers, Wound Application, Other), Procedure (Image-guided Procedures, Ultrasound-guided Procedures, Stereotactic Procedures, CT-guided Procedures, MRI-guided Procedures, Other Image-guided Procedures, Nonimage-Guided Procedures), End User (Hospital & Surgical Centers, Diagnostic & Surgical Centers, Diagnostic Clinics & Pathology Laboratories, Ambulatory Care Centers, Research & Academic Institutes), and Region

The global aspiration & biopsy needles market size was USD 889 Mn in 2021 and is anticipated to reach USD 1,901 Mn in 2031, growing at a rate of 7.9% from 2022 to 2031.

A needle biopsy is a procedure to obtain a sample of cells from the body for laboratory testing. Common needle biopsy procedures comprise fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs. The sample from needle biopsy may assist the doctor to determine what’s causing a mass or lump, an infection, and inflammation. One may undergo imaging tests, such as the computerized tomography (CT) scan or an ultrasound, before needle biopsy. Sometimes these tests are used during the needle biopsy procedure to more accurately locate the area to be biopsied.

Scope of the Report

Global Aspiration & Biopsy Needles Market DriversRising prevalence of cancer

Worldwide, there has been a significant rise in the number of people suffering from cancer. This can be indorsed to a number of factors, like lifestyle changes, unhealthy diets, and growing tobacco consumption. According to estimates from the International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths across the globe. By 2040, the global burden is anticipated to grow to 27.5 million new cancer cases and 16.3 million cancer deaths, majorly due to the growth and aging of the population.

The incidence of cancer is the highest in more-developed regions, but mortality is relatively higher in less-developed countries owing to a lack of access to treatment facilities coupled with the lack of awareness regarding the benefits of early detection. According to the American Cancer Society, about 9.6 million people die from cancer every year, and 70% of cancer deaths occur in low-to-middle income countries like China and India; these proportions are expected to grow further by 2025. With the increasing prevalence of cancer in major regions across the globe, the demand for effective cancer diagnosis is anticipated to increase in the upcoming years. This, in turn, is expected to support the growth of the aspiration and biopsy needles market during the forecast period.

Global Aspiration & Biopsy Needles Market OpportunitiesEmerging economies

Emerging economies (such as India, China, Brazil, and Mexico) are anticipated to offer significant growth opportunities for players operating in the aspiration and biopsy needles market. This can be attributed to improvements in the standard of living, the presence of a huge target population base (as a result of the rising prevalence of cancer), improvements and developments in the healthcare infrastructure, rising healthcare expenditure, and the transformation of healthcare research facilities in these countries. Adding to that, the rapid economic development coupled with rising healthcare expenditure in these emerging countries have improved access to quality healthcare, including quality cancer care.

Global Aspiration & Biopsy Needles Market RestraintsRisk of infection associated with the use of aspiration and biopsy needles

Biopsy needle procedures, like core-needle and fine-needle procedures, assist radiologists and surgeons in examining abnormalities at a particular site. Conversely, patients can contract infections during these procedures as they involve cuts and incisions for extracting tissue samples. Moreover, in several cases, aspiration and biopsy needles are reused, which further increases the risk of infection during these procedures. Even though the reuse of some needles is not recommended by healthcare authorities as well as product manufacturers, this practice is still prevalent, especially in developing economies, which is likely to hamper the growth of the market.

Impact of COVID-19 on Aspiration & Biopsy Needles Market

The COVID-19 pandemic has resulted in a significant drop in cancer screening, cancer management visits, and cancer biopsy procedures worldwide. As a result of forced lockdowns, cancer screening services were disrupted to some extent, which ultimately minimized the demand for biopsy needles. The repercussions of delayed cancer detection owing to COVID-19 were investigated in a study undertaken in the UK and published in Lancet Oncology in March 2021. The study covered data from over 100,000 people with breast, colorectal, oesophageal, or lung cancer. It found that 1- and 5-year cancer survival rates will be severely reduced because of the outbreak of COVID-19, due to the reduction in diagnostic biopsies and lack of availability of screening services. Conversely, numerous physician reports from the US have observed a growing number of screening appointments during the last quarter of 2020, which is expected to boost continually.

Global Aspiration & Biopsy Needles Market Segmental Analysis

The report covers the aspiration and biopsy needles market by product type, application, procedure, end-user, and region.

Global Aspiration & Biopsy Needles Market by Product Type

The various product type comprised in the global aspiration & biopsy needles market are biopsy needles and aspiration needles. The biopsy needles segment is also sub-segmented into CNB needles and VAB needles.

The biopsy needle segment is likely to dominate the market during the forecast period. The key factors such as the rising prevalence of cancer coupled with an increasing preference for minimally invasive diagnostic procedures (over excision biopsies) are boosting the growth of the biopsy needles segment in the global aspiration & biopsy needles market.

Global Aspiration & Biopsy Needles Market by Application

The different applications comprised in the global aspiration & biopsy needles market are tumor/cancer application, wound application, and other applications. The tumor/cancer application segment is also sub-segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, kidney cancer, bone & bone marrow cancer, and other cancer.

The tumor/cancer segment is likely to dominate the market during the forecast period.The higher market share is primarily attributed to the growing prevalence of breast cancer combined with rising awareness about the disease, and increasing research activity pertaining to breast screening and diagnosis is boosting the market share of the segment.

Global Aspiration & Biopsy Needles Market by Procedure

The various procedures such as image-guided procedures, ultrasound-guided procedures, stereotactic procedures, CT-guided procedures, MRI-guided procedures, other image-guided procedures, and nonimage-guided procedures are comprised in the global aspiration & biopsy needles market.

The image-guided procedure accounted for the largest share of the market during the forecast period.The key factors propelling the market growth are the rising preference for minimally invasive biopsy and aspiration procedures.

Global Aspiration & Biopsy Needles Market by End User

The various end-users comprised in the global aspiration & biopsy needles market are hospitals & surgical centers, diagnostic clinics & pathology laboratories, ambulatory care centers, and research & academic institutions.

The hospitals & surgical centers segment is likely to dominate the market during the forecast period. The key factors such as the rising prevalence of cancer coupled with cancer awareness initiatives undertaken by government and global health organizations are boosting the growth of the market.

Geographical Analysis of Global Aspiration & Biopsy Needles Market

The global aspiration & biopsy needles market is analyzed for various key countries of the regions such as North America, Europe, Asia Pacific, and the Rest of the World.

The Asia Pacific is likely to hold the majority of the market share during the forecast period. The increasing initiatives by the government for cancer diagnostic and screening combined with rising research activity and the high incidence of cancer in Asia Pacific countries such as India and China are the major driving factors for the growth of the market.

Market Players of Global Aspiration & Biopsy Needles Market

Key Developments in Global Aspiration & Biopsy Needles Market

• December 2021: Olympus launched the FDA 510(k)- cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope.
• January 2021: Hologic Inc. acquired Somatex Medical Technologies, Hologic’s strategy to provide a comprehensive suite of innovative solutions across the continuum of breast health care.
• May 2019: Argon Medical acquired Mana tech Ltd., its exclusive distributor for the UK and Ireland.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.